Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 29,666

Document Document Title
WO/2016/006380A1
The purpose of the present invention is to provide: a novel europium (III) complex which is a liquid at ordinary temperatures and pressures; and a use thereof. This europium (III) complex comprises: a europium (III) ion coordinated by fo...  
WO/2016/006708A1
A compound represented by general formula (1) is useful as a material for an organic EL element with which it is possible to realize an organic EL element having high light emission efficiency even when driven by a low voltage and having...  
WO/2016/002853A1
The purpose of the present invention is to provide a novel compound that is capable of activating glycogen synthase but hardly activates receptor PPAR and shows high safety. Provided is a compound represented by general formula (I) or a ...  
WO/2016/001204A1
Primarily, the present invention relates to compounds of the formula (I) defined below and to the use thereof as herbicides, in particular for controlling broad-leaved weeds and/or weed grasses in crops of useful plants and/or as plant g...  
WO/2016/001441A1
The invention relates to compounds of the following general formula (I) in the form of one of the enantiomers thereof or a mixture of the enantiomers thereof, and the pharmaceutically acceptable salts and/or solvates thereof, especially ...  
WO/2015/197699A1
The present invention relates to a process of making furan-2,5-dicarboxylic acid, comprising the following steps: (a) subjecting a starting mixture comprising 5-(hydroxymethyl)furfural and water to oxidation conditions in the presence of...  
WO/2015/200514A3
Provided herein are compounds of the formulas: (I) wherein: n, X2, R3, R3', R4, R4', R5, R5', R6, and R6' are as defined herein. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds may be used...  
WO/2015/197860A3
Present invention relates to a novel and efficient method of preparing thapsigargin analogues. Present invention also relates to specific compounds and their use for the preparation of thapsigargin analogues.  
WO/2015/198351A9
The invention discloses Ni containing anionic clay catalyst and its preparation thereof useful for selective hydrogenation of furfural to furfuryl alcohol. Particularly the invention discloses a novel catalyst system comprising Ni over a...  
WO/2015/198351A3
The invention discloses Ni containing anionic clay catalyst and its preparation thereof useful for selective hydrogenation of furfural to furfuryl alcohol. Particularly the invention discloses a novel catalyst system comprising Ni over a...  
WO/2015/198563A1
[Problem] To provide a highly efficient, low drive voltage organic electroluminescent element with long service life, by combining, as materials for highly efficient, highly durable organic electoluminescent elements, different materials...  
WO/2015/196228A1
The invention relates to compounds of formula (II) for use as drugs that selectively inhibit the proliferation of SMCs in comparison with the proliferation of ECs: formula (II), wherein R1 to R6 are selected from -H, -F, -CH3, -CF3, -CF2...  
WO/2015/197860A2
Present invention relates to a novel and efficient method of preparing thapsigargin analogues. Present invention also relates to specific compounds and their use for the preparation of thapsigargin analogues.  
WO/2015/193364A1
Process for the selective production of oxidized furan derivatives starting from 5-hydroxymethyl-2-furfural in the presence of a solvent, an oxidation agent, a catalyst, and optionally a base, which process is characterized in that the o...  
WO/2015/194791A2
A compound represented by chemical formula 1 is disclosed. In addition, an organic electronic element comprising a first electrode, a second electrode and an organic layer between the first electrode and the second electrode is disclosed...  
WO/2015/194791A3
A compound represented by chemical formula 1 is disclosed. In addition, an organic electronic element comprising a first electrode, a second electrode and an organic layer between the first electrode and the second electrode is disclosed...  
WO/2015/194568A1
 Provided is a method for purifying industrially useful tetrahydrofuran (THF) in which the purification load can be reduced and which serves as a starting material for manufacturing a polyether polyol having excellent hue, by convertin...  
WO/2015/192672A1
Disclosed are a benzofuran derivative having a structure represented by general formula I or a pharmaceutically acceptable salt thereof, a preparation method therefor, and an application thereof in preparation of antiarrhythmic drugs. Th...  
WO/2015/194839A1
The present disclosure relates to an electron buffering material, and an organic electroluminescent device comprising a first electrode, a second electrode facing the first electrode, a light-emitting layer between the first electrode an...  
WO/2015/189796A1
The invention relates to a composition of isomers of mono-alkyl ethers of monoanhydro-hexitol having an alkyl ether radical (OR) at C-3, C-5 or C-6 of the monoanhydro-hexitol, in which the alkyl group (R) is a linear or branched, cyclic ...  
WO/2015/191900A1
Provided herein are compounds, including enantiomerically pure forms thereof, and pharmaceutically acceptable salts or co-crystals and prodrugs thereof which have glucagon receptor antagonist or inverse agonist activity. Further, provide...  
WO/2015/190489A1
 The purpose of the present invention is to provide a useful prodrug compound of a naphthofuran compound. The present invention pertains to a compound represented by general formula (IA): (the symbols in the formula are as stated in th...  
WO/2015/189554A1
The present invention provides apalladium(II)complex of formula (1) or a palladium(II) complex of formula (2). R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R18, R19, R20, R21, R22, R23 and R24, m, E and X are described in the speci...  
WO/2015/188661A1
The present invention relates to an asymmetrical dioxime ester compound represented by general formula I and manufacturing method thereof. In general formula I, Ar1 is C6-C20 o-arylene or C3-C20 O-hetroarylene substituted by X1; Ar2 is C...  
WO/2015/189481A1
The present invention relates to selective catalytic dehydroxylation method of aldaric acids for producing muconic acid and furan chemicals, which can be used directly in fine chemical and polymer applications (FCA/FDCA) and as intermedi...  
WO/2015/191653A1
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV:  
WO/2015/187082A1
The present invention relates to new plasma lipid lowering compounds and pharmacological compositions,and their use in the prophylaxis, prevention and treatment of hyperlipidemia, including hypertriglyceridemia, hyperlipoproteinemia, and...  
WO/2015/187347A1
A continuous process for producing hemicellulose sugars from a biomass extraction liquor is provided. A system is configured for continuously producing hemicellulose sugars and/or hemicellulose derivatives from a biomass extraction liquo...  
WO/2015/186065A1
The present invention provides a process for the preparation of 4- dimethylaminocrotonic acid of Formula (II) or its salts, which is used as an intermediate for the preparation of afatinib or its salts.  
WO/2015/181186A1
The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions con...  
WO/2015/181490A1
The invention relates to the use of a product for internal dehydration of hydrogenated sugar as a methanogen substrate in a method for biogas production, a composition comprising a monoanhydrohexitol (M), a dianhydrohexitol (D), and anhy...  
WO/2015/178585A1
Disclosed is a compound represented by Chemical Formula 1. Also disclosed is an electro-organic device including a first electrode, a second electrode, and an organic layer between the first electrode and the second electrode, wherein th...  
WO/2015/179427A1
The present invention is directed to methods for preparing Beraprost and novel synthetic intermediates for Beraprost. In one aspect, a process is provided to produce a pharmaceutical compound represented by the general Formula (I) via a ...  
WO/2015/177674A1
Provided are polynucleotides encoding polypeptides involved in the biosynthesis of cornexistin and hydroxycornexistin as well as vectors and recombinant microorganisms comprising the polynucleotides. Also provided are methods for the pro...  
WO/2015/179392A1
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV : ...  
WO/2015/179088A1
The present invention provides methods of synthesis of di-, tri-, and poly- ester derivatives of 5- methyl-2-furoic acid; di-, tri-, and poly- amide derivatives of 5-methyl-2-furoic acid; and di-, tri-, and poly- thioester derivatives of...  
WO/2015/179038A3
Disclosed are compounds of Formula (I), including all stereoisomers, (N-oxides), and salts thereof, wherein A and R are as defined in the disclosure. Also disclosed is a method for preparing a compound of Formula (I), comprising reacting...  
WO/2015/179426A1
Disclosed herein are flame retardant compounds and polymer compositions containing these flame retardant compounds. The flame retardant compounds can be derived from biological sources and can include coordinated metal ions.  
WO/2015/174639A1
Disclosed are an organic compound represented by formula 1, an organic optoelectric diode applying the organic compound, and a display device comprising the organic optoelectric diode.  
WO/2015/174682A1
The present invention relates to a heterocyclic compound containing an aromatic amine group and an organic light-emitting device comprising the same and, more specifically, to a heterocyclic compound and an organic light-emitting device ...  
WO/2015/174840A1
The invention concerns a process for the production of furfural from pentoses and/or water soluble pentosans, comprising the steps of feeding an aqueous pentose solution containing one or more pentoses or soluble pentosans to the bottom ...  
WO/2015/174640A1
The present invention relates to a compound represented by formula 1, an organic optoelectronic element comprising the same, and a display device comprising the organic optoelectronic element. Formula 1 and the description regarding the ...  
WO/2015/171704A1
Disclosed is an oxidation process to produce a crude carboxylic acid product carboxylic acid product. The process comprises oxidizing a feed stream comprising at least one oxidizable compound to generate a crude carboxylic acid slurry co...  
WO/2015/170718A1
The present invention addresses the problem of providing an industrially advantageous method for purifying a furfural composition with high efficiency while steadily reducing the production of a solid matter which cannot be controlled by...  
WO/2015/170688A1
Provided is a metal-supported catalyst comprising a porous coordination polymer as a carrier (a metal-supported porous coordination polymer catalyst), said catalyst having an excellent catalytic activity and being applicable to various k...  
WO/2015/165352A1
The present invention provides a compound with a structure represented by general formula I or a pharmaceutically acceptable salt thereof, a preparation method for the compound or the salt, and a use of the compound or the pharmaceutical...  
WO/2015/162538A1
The invention relates to heterocyclic compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their pharmaceutical compositions for use in medicine for the treatment of ...  
WO/2015/163936A1
The present invention relates to novel bicyclic derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.  
WO/2015/162230A1
The invention relates to a catalytic converter arrangement for producing phthalic anhydride by means of a gas phase oxidation of aromatic hydrocarbons, comprising a reactor with a gas inlet side for a reactant gas, a gas outlet side for ...  
WO/2015/163314A1
 A compound represented by general formula (1): (in formula (1), A shows a C6-30 divalent aromatic group for forming an aromatic ring, or the like, and the plurality of R1 each independently show a hydrogen atom or the like), tetracarb...  

Matches 201 - 250 out of 29,666